Quetiapine Production Cost Reports

The report provides a detailed analysis essential for establishing a Quetiapine production plant. It encompasses all critical aspects necessary for Quetiapine production, including the cost of Quetiapine production, Quetiapine plant cost, Quetiapine production costs, and the overall Quetiapine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Quetiapine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Quetiapine (brand name Seroquel) is an atypical antipsychotic medication utilised as an active pharmaceutical ingredient (API) in the pharmaceutical industry. It is widely used for treating mental health disorders such as schizophrenia, bipolar disorder, and major depressive disorder. It works by balancing the levels of neurotransmitters like dopamine and serotonin in the brain. The industrial production of quetiapine involves the synthesis of specific intermediate chemicals that are crucial for creating the complex molecular structure of the drug. These intermediates are essential for ensuring the purity, efficacy, and safety of the final pharmaceutical product.

The key market drivers for quetiapine include the increasing cases of mental health disorders such as schizophrenia, bipolar disorder, and major depressive disorder, which increase demand for effective antipsychotic treatments worldwide. Growing awareness, reduced stigma around mental health, and a larger ageing population contribute to an expanding market. Additionally, research and development efforts to create new formulations and extended-release versions of quetiapine further enhance market growth. Also, patent expirations facilitate the entry of generic versions, making the drug more accessible and affordable, which also drives demand. Advances in drug delivery systems, favourable insurance coverage, and updated treatment guidelines support increased usage.

Factors such as the availability and quality of specific intermediate chemicals, such as Dibenzo[b,f]thiazepin-11-one and 1-[2-(2-Hydroxyethoxy)ethyl]piperazine, directly impact industrial quetiapine procurement. Additionally, procurement is affected by the complexity and cost of the chemical synthesis process, which involves multiple solvents and reactions requiring precise control to meet purity standards.

Raw Material for Quetiapine Production

According to the Quetiapine production plant project report, the various raw materials for Quetiapine production include chloronitrobenzene- thiophenol.

Production Process of Quetiapine

The extensive Quetiapine production cost report consists of the following major industrial production process:

1. Production via an etherification reaction: The production process of quetiapine begins with the preparation of o-nitrodiphenyl sulfide from o-chloronitrobenzene and thiophenol via an etherification reaction. The o-nitrodiphenyl sulfide is then hydrogenated using Raney nickel as a catalyst to produce the corresponding amine. This amine reacts with phosgene to form isocyanatodiphenyl sulfide. In the next step, the isocyanate is heated in the presence of aluminium chloride (AlCl3) and o-dichlorobenzene to form dibenzo[b,f]thiazepine-11(10H)-one. This compound is then treated with phosphorus oxychloride (POCl3) and dimethylaniline to produce an intermediate iminochloride. Finally, this intermediate reacts with 2-(2-(piperazin-1-yl)ethoxy)ethanol to yield the final product, quetiapine.

Properties of Quetiapine

Quetiapine is a dibenzothiazepine derivative with the molecular formula C21H25N3O2S and a molecular weight of 383.51 g/mol. It appears as a white to off-white crystalline powder and is moderately soluble in water. It has a melting point in the range of 172-173 degree Celsius. It acts as an antagonist on multiple neurotransmitter receptors, including dopamine (D1-D5), serotonin (5-HT1A partial agonist and other antagonists), adrenergic (α1 and α2), histamine (H1), and muscarinic acetylcholine receptors, which underlie its therapeutic effects. It has one hydrogen bond donor, six rotatable bonds, and a topological polar surface area of 73.6 Ų, reflecting its moderate polarity and molecular flexibility.